Insider · CIK 0002051759
Bryan Dechairo
cooofficer
Files at WGS (GeneDx Holdings Corp.). First filing Feb 3, 2026, latest Feb 6, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $851k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
WGS: GeneDx Holdings Corp.
WGSOct 9, 2026 · close 67.33
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | GeneDx Holdings Corp. | $511k 5,961 shares | -100% | +51% from low-49% from high | |
| 45Moderate | GeneDx Holdings Corp. | $340k 3,413 shares | -36% | +76% from low-41% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +10,430 | $0.00 | $0 | 10,430 | Mar 5, 2026 |
| Feb 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -779 | $83.04 | $65k | 5,182 | Feb 6, 2026 |
| Feb 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,425 | $83.83 | $119k | 3,757 | Feb 6, 2026 |
| Feb 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,034 | $84.93 | $88k | 2,723 | Feb 6, 2026 |
| Feb 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -623 | $86.35 | $54k | 2,100 | Feb 6, 2026 |
| Feb 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -1,572 | $87.66 | $138k | 528 | Feb 6, 2026 |
| Feb 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -328 | $88.66 | $29k | 200 | Feb 6, 2026 |
| Feb 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -100 | $90.45 | $9,045 | 100 | Feb 6, 2026 |
| Feb 4, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock10b5-1 | -100 | $91.92 | $9,192 | 0 | Feb 6, 2026 |
| Feb 1, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +9,374 | $0.00 | $0 | 9,374 | Feb 3, 2026 |
| Feb 2, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -93 | $96.77 | $8,999 | 9,281 | Feb 3, 2026 |
| Feb 2, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -492 | $98.61 | $49k | 8,789 | Feb 3, 2026 |
| Feb 2, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,662 | $99.40 | $165k | 7,127 | Feb 3, 2026 |
| Feb 2, 2026 | WGS GeneDx Holdings Corp. | SOpen-market sale Class A Common Stock | -1,166 | $100.31 | $117k | 5,961 | Feb 3, 2026 |
| Feb 1, 2026 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -9,374 | $0.00 | $0 | 28,123 | Feb 3, 2026 |
| Jan 14, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +37,497 | $0.00 | $0 | 37,497 | Jan 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.